edits.seer.internal.rules.IFN2965.xml Maven / Gradle / Ivy
Go to download
Show more of this group Show more artifacts with this name
Show all versions of validation-edits-seer Show documentation
Show all versions of validation-edits-seer Show documentation
Java implemenation of the SEER edits.
<rule id="IFN2965" name="Schema ID, Site, Histo, Schema Discriminator 1 (NAACCR)" tag="N2965" java-path="lines.line" category="inter-field" depends="Primary_Site,Year_of_Diagnosis">
<expression><![CDATA[if (line.dateOfDiagnosisYear == null || line.dateOfDiagnosisYear < '2018')
return true
if (line.primarySite == null || line.histologicTypeIcdO3 == null)
return true
Integer siteInt = Functions.asInt(line.primarySite.substring(1,4))
Map contextMap = (Map)Context.IFN2965_Table
if (!contextMap.containsKey(siteInt))
return line.schemaDiscriminator1 == null
else {
Map histologyMap = (Map)contextMap.get(siteInt)
Integer histInt = Functions.asInt(line.histologicTypeIcdO3)
if (!histologyMap.containsKey(histInt))
return line.schemaDiscriminator1 == null
List schemaIds = (List)(histologyMap.get(histInt))
if (schemaIds != null && schemaIds.contains(line.schemaId)) {
Map discrimMap = (Map)Context.IFN2965_Schema_ID_Table
List validDiscrims = (List)discrimMap.get(line.schemaId)
return validDiscrims.contains(line.schemaDiscriminator1)
}
else
return false
}
return true]]></expression>
<message>Primary Site, Histologic Type ICD-O-3, and Schema Discriminator 1 are incompatible with Schema ID.</message>
<description><![CDATA[This edit verifies that Schema Discriminator 1, where required, is used where
the Primary Site and Histologic Type ICD-O-3 codes are not sufficient to
identify the appropriate Schema ID. Schema Discriminator 1 code is
used to distinguish between multiple meanings for these codes where required
for Schema ID assignment.
For example, for topography code C240, Schema Discriminator 1 code 3 is
assigned if the primary site is cystic duct, Schema ID 00240; code 1, 5, 6
or 9 is assigned if the primary site is perihilar bile ducts, Schema ID
00250; code 4 or 7 is assigned if the primary site is distal bile ducts,
Schema ID 00260. Schema Discriminator 1 is only required for the primary
site codes or histologies listed for each Schema ID; there may be other
primary site codes or histologies within the Schema ID that do not require
Schema Discriminator 1, and Schema Discriminator 1 must be left blank if
not required.
Schema Discriminator 1 is used for staging information rather than Schema ID
assignment for SchemaIDs 00430, 00730, 00740, and 00821.
The edit checks that Schema ID, Primary Site code or Histologic Type ICD-O-3
code, and Schema Discriminator 1 code occur together within the edited
record, as shown in the following chart. If there is an edit failure, the
problem may be due to a software error. If coding is reviewed and correct,
the software vendor should be consulted for assistance in resolving the
issue.
1. The edit is skipped for the following conditions:
a. Date of diagnosis before 2018, blank (unknown), or invalid.
b. Primary Site is blank
c. Histologic Type ICD-O-3 is blank
2. The edit checks that Schema Discriminator 1 is coded and not blank for
Primary Site and/or Histologic Type ICD-O-3 as required. The combinations
of site and histology are determined by Schema ID but are checked
independently of Schema ID assignment.
3. The edit then verifies that Schema Discriminator 1 is valid for Primary Site,
Histologic Type ICD-O-3, and Schema ID. Where SITE or HISTO is listed as "All",
Schema Discriminator 1 is required for all the sites or histologies assigned to the
Schema ID. Where a specific site or histology is listed, Schema Discriminator 1
is required for only those sites or histologies for the Schema ID.
SCHEMA ID SITE HISTO DISC 1
00060 Cervical Lymph Nodes, C760 All 2,3,4,5
Unknown Primary of Head and Neck
00090 Nasopharynx C111 All 1
00100 Oropharynx (p16+) C111 All 2
00111 Oropharynx (p16-) C111 All 2
00161 Esophagus Squamous C160 All 2
00169 Esophagus excluding Squamous C160 All 2
00170 Stomach C160 All 0,3,9
00242 Cystic Duct C240 All 3
00250 Bile Ducts Perihilar C240 All 1,5,6,9
00260 Bile Ducts Distal C240 All 4,7
00430 GIST C481 All 1,2,9
00459 Soft Tissue Other C760 8941 0,1
00631 Urethra C680 All 1
00633 Urethra-Prostatic C680 All 2
00671 Melanoma Iris C694 All 2
00672 Melanoma Choroid and Ciliary Body C694 All 1
00690 Lacrimal Gland C695 All 1
00698 Lacrimal Sac C695 All 2,9
00730 Thyroid C739 All 1,2
00740 Thyroid - Medullary C739 All 1,2
00790 Lymphoma All 9591 3,9
00821 Plasma Cell Myeloma All 9732 0,1,9
00830 HemeRetic All 9591 1,2
99999 Ill-Defined Other C760 Some* 0,1
*Histologies requiring Schema Discriminator 1 for 99999:
8010, 8046, 8051-8052, 8070-8074, 8082-8084, 8121, 8140, 8147, 8200, 8310, 8430,
8450, 8480, 8525,8550, 8562
4. The edit verifies that Schema Discriminator 1 is blank for all other
Primary Site or Histologic Type ICD-O-3 codes in the Schema ID.
5. The edit verifies that Schema Discriminator 1 is left blank for all other
Schema IDs.
6. Where Schema Discriminator 2 is also required to assign the correct Schema ID,
the edit will pass either Schema ID as correct. The Schema IDs include 00100 and
00111, and 00161 and 00169 with histology 8020.
SCHEMA ID-
SITE OR HISTO SCHEMA DISCRIMINATOR 1 CODES AND DEFINITIONS
00060-C760 2: Not tested for EBV or p16 in head and neck regional nodes
(EBV and p16 both unknown)
3: Unknown EBV, p16 negative in head and neck regional nodes
4: Unknown p16, EBV negative in head and neck regional nodes
5: Negative for both EBV and p16 in head and neck regional
nodes
00090-C111 1: Posterior wall of nasopharynx, NOS
00100-C111 2: Adenoid; pharyngeal tonsil
00111-C111
00161-C160 2: INVOLVEMENT of esophagus or esophagogastric junction (EGJ)
00169-C160 AND epicenter LESS THAN or EQUAL TO 2 cm into the proximal
stomach
00170-C160 0: NO involvement of esophagus or gastroesophageal junction
AND epicenter at ANY DISTANCE into the proximal stomach
(including distance unknown)
3: INVOLVEMENT of esophagus or esophagogastric junction (EGJ)
AND epicenter GREATER THAN 2 cm into the proximal stomach
9: UNKNOWN involvement of esophagus or gastroesophageal
junction
AND epicenter at ANY DISTANCE into the proximal stomach
(including distance unknown
00242-C240 3: Cystic bile duct; cystic duct
00250-C240 1: Perihilar bile duct(s)
Proximal extrahepatic bile duct(s); Hepatic duct(s)
5: Diffuse involvement
More than one subsite involved, subsite of origin not stated
6: Stated as middle extrahepatic bile duct
AND treated with combined hepatic and hilar resection
9: Extrahepatic bile ducts, NOS
00260-C240 4: Distal bile duct; Common bile duct; Common duct, NOS
7: Stated as middle extrahepatic bile duct
AND treated with combined hepatic and hilar resection
00430-C481 1: Mesentery; Mesoappendix; Mesocolon; Pelvic peritoneum;
Rectouterine pouch: Cul de sac, Pouch of Douglas;
Other specified peritoneal site
2: Omentum
9: Unknown or no information; Not documented in medical record
00459-C760 0: Not occult
1: Occult, Negative cervical nodes (regional head and neck nodes)
00631-C680 1: Male penile urethra; Female urethra: Urethral gland;
00633-C680 Cowper gland; Urethra, NOS
2: Males only: Prostatic urethra, Prostatic utricle
00671-C694 2: Iris
00672-C694 1: Ciliary Body; Crystalline lens; Sclera; Uveal tract;
Intraocular; Eyeball
00690-C695 1: Lacrimal gland
00698-C695 2: Lacrimal sac; Lacrimal duct, NOS; Nasal lacrimal duct/sac;
Nasolacrimal duct
9: Lacrimal, NOS
00730-C739 1: Thyroid gland; Thyroid, NOS
00740-C739 2: Thyroglossal duct cyst
00790-9591 3: Splenic diffuse red pulp small B-cell lymphoma
Splenic marginal zone lymphoma, diffuse variant
Splenic red pulp lymphoma with numerous basophilic villous
lymphocytes
Splenic lymphoma with villous lymphocytes
9: Non-Hodgkin lymphoma, NOS
Any other terminology describing non-Hodgkin lymphoma, NOS
00821 0: Multiple myeloma
Myeloma, NOS
Non-secretory myeloma
Plasma cell myeloma (PCM)
Ultra-High-Risk Smoldering MM (SMM)
1: Smoldering plasma cell myeloma (SPCM)
Asymptomatic plasma cell myeloma
Early myeloma
Evolving myeloma
9: Other terminology describing myeloma
Unknown terminology used
00830-9591 1: Splenic B-cell lymphoma/leukemia, unclassifiable
2: Hairy cell leukemia variant
Prolymphocytic variant of hairy cell leukemia
99999-C760 0: Not occult
1: Occult, Negative cervical nodes (regional head and neck nodes)]]></description>
<history>
<event version="SE18-018-10" user="kirbyk" date="2018-12-05" ref="68065">Edit created.</event>
<event version="SE18-019-01" user="kirbyk" date="2019-03-11" ref="68090">Fixed table values and description and turned edit back on; changed edit name.</event>
<event version="SE18-019-01" user="kirbyk" date="2019-04-15" ref="68168">Removed skip conditions for Schema ID.</event>
<event version="SE18-020-01" user="depryf" date="2020-02-04" ref="68281">Changed property names to align with NAACCR XML IDs.</event>
<event version="SE21-021-04" user="kirbyk" date="2021-04-12" ref="68595">Updated edit logic and table for 2021.</event>
<event version="SE22-022-01" user="beverung" date="2022-02-07" ref="68779">Update table for 2022.</event>
</history>
</rule>